![](https://www.bayareaeconomy.org/wp-content/uploads/2016/02/261445720_2f253a1336_o.jpg)
“It isn’t all about the “omics” in precision medicine. Unless you have the clinical context that sits around these samples, then it’s actually of very limited value. What I mean by that is you need to be able to integrate the genomic data with the EMR data with the claims data with the self-reported patient data remote patient monitoring wearables [and] images.” –Jonathan Sheldon
Click here to view Jonathan Sheldon’s presentation materials.